abcArquivos Brasileiros de CardiologiaArq. Bras. Cardiol.0066-782X1678-4170Sociedade Brasileira de Cardiologia - SBCSão Paulo, SP, BrazilpmSh9Tt3XqvkDZMkJm8DRJg00006S0066-782X2002001200006S0066-782X(02)0790030610.1590/S0066-782X2002001200006Original ArticlesDetection of Altered Risk Factors in Hospitalized Patients with Coronary Artery DiseasePereiraAvany FernandesSantosMaria Dorotéia Borges dosCicognaAntônio CarlosPadovaniCarlos RobertoSoaresEliane de AbreuBuriniRoberto CarlosBotucatuSão PauloUniversidade Estadual PaulistaFaculdade de Medicina de Botucatu Brazil092002793263268This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
OBJECTIVE: To assess biochemical, anthropometric, and dietary variables considered risk factors for coronary artery disease. METHODS: Using anthropometrics, dietary allowance, and blood biochemistry, we assessed 84 patients [54 males (mean age of 55± 8 years) and 30 females (mean age of 57±7 years)], who had severe ( > or = 70% coronary artery obstruction) and nonsevere forms of coronary artery disease determined by cardiac catheterization. The severe form of the disease prevailed in 70% of the males and 64% of the females, and a high frequency of familial antecedents (92% ' 88%) and history of acute myocardial infarction (80% ' 70%) were observed. Smoking predominated among males (65%) and diabetes mellitus among females (43%). RESULTS: Males and females had body mass index and body fat above the normal values. Females with nonsevere lesions had HDL > 35 mg/dL, and this constituted a discriminating intergroup indicator. Regardless of the severity of the disease, hyperglycemia and hypertriglyceridemia were found among females, and cholesterolemia > 200 mg/dL in both sexes, but only males had LDL fraction > 160 mg/dL and homocysteine > 11.7 mmol/L. The male dietary allowance was inadequate in nutrients for homocysteine metabolism and in nutrients with an antioxidant action, such as the vitamins B6, C, and folate. Individuals of both sexes had a higher lipid and cholesterol intake and an inadequate consumption of fiber. The diet was classified as high-protein, high-fat, and low-carbohydrate. CONCLUSION: The alterations found had no association with the severity of lesions, indicating the need for more effective nutritional intervention.
risk factorsindividuals with coronary artery diseasehospitalization09102002
Original Article
Detection of Altered Risk Factors in Hospitalized Patients with Coronary Artery Disease
Avany Fernandes Pereira, Maria Dorotéia Borges dos Santos, Antônio Carlos Cicogna, Carlos Roberto Padovani, Eliane de Abreu Soares, Roberto Carlos Burini
Botucatu, SP - Brazil
OBJECTIVE: To assess biochemical, anthropometric, and dietary variables considered risk factors for coronary artery disease.
METHODS: Using anthropometrics, dietary allowance, and blood biochemistry, we assessed 84 patients [54 males (mean age of 55±8 years) and 30 females (mean age of 57±7 years)], who had severe (³ 70% coronary artery obstruction) and nonsevere forms of coronary artery disease determined by cardiac catheterization. The severe form of the disease prevailed in 70% of the males and 64% of the females, and a high frequency of familial antecedents (92% ' 88%) and history of acute myocardial infarction (80% ' 70%) were observed. Smoking predominated among males (65%) and diabetes mellitus among females (43%).
RESULTS: Males and females had body mass index and body fat above the normal values. Females with nonsevere lesions had HDL > 35 mg/dL, and this constituted a discriminating intergroup indicator. Regardless of the severity of the disease, hyperglycemia and hypertriglyceridemia were found among females, and cholesterolemia > 200 mg/dL in both sexes, but only males had LDL fraction > 160 mg/dL and homocysteine > 11.7 mmol/L. The male dietary allowance was inadequate in nutrients for homocysteine metabolism and in nutrients with an antioxidant action, such as the vitamins B6, C, and folate. Individuals of both sexes had a higher lipid and cholesterol intake and an inadequate consumption of fiber. The diet was classified as high-protein, high-fat, and low-carbohydrate.
CONCLUSION: The alterations found had no association with the severity of lesions, indicating the need for more effective nutritional intervention.
Key words: risk factors, individuals with coronary artery disease, hospitalization
In the past few years, a marked reduction in mortality due to cardiovascular diseases has occurred, even though those diseases remain the major cause of mortality worldwide according to the American Heart Association 1.
The multifactorial etiology of coronary artery disease reveals the existence of several risk indicators, many of which may be modified by effective interventions 2. On the other hand, some studies show that the risk factors, when kept active, contribute to the progression of coronary lesions, worsening the patient's prognosis 3.
According to dietary recommendations for preventing coronary artery disease, the factors related to its development or worsening, or both, are the following: total fat intake above 30% and saturated fatty acid intake above 10% of the total caloric value of the diet; dietary cholesterol above 300 mg/day; inadequate intake of vitamins and antioxidant minerals and of vitamins involved in the metabolism of methionine; dietary fiber below 20 g/day; sodium consumption above 6 g/day; and high-caloric diets 4-7.
The current study assessed the levels of factors associated with coronary artery disease in patients hospitalized due to coronary artery disease, aiming at checking whether the severity of the coronary artery lesion was related to the alterations in risk factors.
Methods
We carried out a cross-sectional observational study with 84 patients hospitalized for the treatment of coronary artery disease in a ward of a public general hospital affiliated with the School of Medicine of Botucatu in the Central-Western region of the State of São Paulo, from March to August 1998. The inclusion criterion was the diagnosis of coronary artery disease through clinical examination and cardiac catheterization. The exclusion criteria were as follows: hospitalization time insufficient for data collection, presence of severe cardiac disease making the patient's assessment impossible, recent acute myocardial infarction (time £ 3 months in regard to the period studied), and presence of other chronic diseases, such as decompensated diabetes mellitus, renal, respiratory, or hepatic insufficiency, and cancer.
The individuals were divided into 4 groups according to sex and the severity of the coronary artery lesion using the criterion of the Sociedade de Cardiologia do Estado de São Paulo 8, which considers coronary artery obstruction ³ 70% as a severe lesion. The groups were as follows: groups 1 and 2 (G1 and G2) comprised 57 (38 males and 19 females) patients with severe coronary lesions; groups 3 and 4 (G3 and G4) comprised 27 (16 males and 11 females) patients with nonsevere coronary artery lesions.
This study was approved by the Committee on Ethics and Research in Human Beings of the School of Medicine of Botucatu.
A personal questionnaire was used to characterize the patients studied with information on sex, age, marital status, smoking status, occurrence of acute myocardial infarction, systemic hypertension, diabetes mellitus, angina pectoris, and hospitalization duration. The severity of the coronary artery disease was established with the analysis of the cardiac catheterization and after clinical examination.
The anthropometric examination comprised the following measurements: weight; height; triceps, biceps, subscapular, and supra-iliac skinfolds (using the Lange® caliper, USA); arm, waist, and hip circumferences (using the millimetric nonextendable tape); and subsequent calculation of the muscle circumference of the arm, waist/hip ratio, and body mass index 9-11. The sum of the skinfold values was determined and the Durnin and Wormesley method was applied 12.
The following reference values were used: the World Health Organization (WHO) standard 13 for body mass index, the Frisancho 14 standard for the arm circumference and the muscle circumference of the arm, and the Bray standard 15 for the waist/hip ratio. The normal ranges for body fat were 15-18% for males and 20-25% for females 16.
The dietary inquiry was applied on the 1st day of hospitalization using a 24-hour recall. To increase the reliability of the measuring spoon measurements reported by the interviewees, the manual of photographic record for dietary inquiries was used as support material 17. In addition to the structured 24-hour recall, we used a questionnaire about the preferred way of preparing food, appetite, allergies, food aversions and preferences, number of meals/day, and use of vitamin and mineral supplements.
To analyze the quantitative data of food intake, measuring spoon measurements of food and beverages reported by the interviewees were converted into grams according to Soares et al 18 and Pinheiro et al 19.
The intake of energy, proteins, lipids, carbohydrates, unsaturated lipids, dietary cholesterol, vitamins C and E, folic acid, vitamins B6 and B12, and dietary fiber was calculated with the aid of Virtual Nutry software 20.
The values obtained were then compared with the dietary aliquots recommended by the National Research Council/Recommended Dietary Allowances (NRC/RDA-1989) 21. In regard to adequacy, the individuals were grouped into the 3 following consumption ranges: < 67% of adequacy (inadequate), from 67% to 100% (borderline), and ³ 100% of adequacy (adequate). The World Health Organization standards were adopted for daily dietary fiber intake 7. Lipid consumption was compared with the values recommended by the National Cholesterol Education Program 5 for the percent dietary fat in relation to the total energy value, dietary cholesterol, and unsaturated lipids.
The biochemical analyses performed in venous blood samples were obtained after nocturnal fasting ranging from 8 to 12 hours, through venous puncture with a closed vacuum system (Vacutainer ® - England). The samples were then centrifuged for 10 minutes (3000 rpm) and the decanted plasma was analyzed with an automatic analyzer (model RAXT OU Ra 1000 - Technicon ® - USA). The following plasma measurements were performed: glucose, total cholesterol, HDL-cholesterol, triglycerides, and total homocysteine, the latter with a high-performance liquid chromatographic assay 22.
LDL-cholesterol was calculated with the Friedewald formula 23 and the total cholesterol/HDL-cholesterol ratio, and the values were compared with the normal values by Castelli et al 24.
The lipid levels were compared with those recommended by the 2º Consenso Brasileiro sobre Dislipidemias 25 (2nd Brazilian Consensus on Dyslipidemias). The normal glycemia range was established from 70 to 110 mg/dL according to the criteria of the American Diabetes Association 26.
The reference values used for homocysteine ranged from 4.90 to 11.70 µmol/L according to Ubbink et al 24.
The statistical analysis was performed with the analysis of variance (ANOVA) for the values of score-z and median, applying the study of comparison between the groups through the nonparametric analog of analysis of variance (Kruskal-Wallis test) complemented by its respective test of multiple comparisons 27.
The results were discussed based on the significance level of 5% (p < 0.005).
Results
Analyzing the characteristics of the sample, we observed that most patients were males (64%), acute myocardial infarction predominated in approximately 80% of the males and in 70% of the females, the mean age was similar for males and females (55±8 and 57±7 years, respectively), a positive familial history of coronary artery disease predominated in both sexes, and tobacco use was more prevalent among males (42%).
Other diseases, such as arterial hypertension and angina pectoris, were also observed in males and females. Severe coronary artery lesions were extremely prevalent and detected in 70% of the males and in 64% of the females (tab. I).
Of the anthropometric values, the percent body fat of males was above 18% and of females above 25%. In regard to the distribution of body fat, the waist/hip ratio was greater in the 2 male groups (G1 and G3) as compared with the female group with nonsevere lesions (tab. II).
The median values of body mass index did not statistically differ among the groups studied, and individuals of both sexes were classified as preobese according to the Reports of WHO 28 (tab. II).
In regard to biochemical values, homocysteinemia was greater in the male sex, regardless of the severity of the coronary artery disease (tab. II).
Of the remaining plasma parameters analyzed, only triglycerides showed a statistical difference in the groups; lower values were found in the male groups (G1 and G3) than those found in females with severe coronary artery lesion (G2) (tab. II).
The HDL-cholesterol and LDL-cholesterol values were similar in both groups. Total cholesterol levels were above the recommended values in all groups, and they showed no significant differences according to the severity of the disease (tab. II).
The total cholesterol/HDL-cholesterol ratios showed significant difference with sexes, and both groups had increased values, which was compatible with an increased risk for coronary artery disease (tab. II). This ratio was higher in males with severe coronary artery lesions, showing a significant correlation with the type of lesion in the male sex (tab. II). Both G3 and G2 had glycemia results above those recommended with no relation to the severity of the lesions (tab. II).
In regard to diet, the percentage contribution of macronutrients characterized the diet as high-fat, high-protein, and low-carbohydrate for both sexes (fig. 1). Analyzing the amount of protein consumed according to body weight, the diet was considered high-protein with protein consumption above 1g/kg/day for all groups studied. The assessment of dietary quantitative consumption revealed an increased ingestion of total lipids in both sexes. The excessive ingestion of dietary cholesterol was also significantly higher in males as compared with that in females in all groups. On the other hand, an insufficient ingestion of unsaturated lipids was observed in both sexes, and it was more significant in males than in females (tab. III). The consumption of dietary fiber was lower than that recommended, with no statistical differentiation between the groups studied (tab. III). In addition, only 13% of the males and 6% of the females reached the adequate level of at least 30 g/day proposed by WHO 7.
In regard to dietary vitamin intake, the median intake observed in isolation showed no dietary inadequacy. However, when the percentage of individuals with adequate consumption according to RDA 21 was analyzed, the results showed that of the vitamins with antioxidant potential, vitamin C was consumed more by the female groups, regardless of the severity of the coronary lesions (tab. III). This resulted in a significantly greater adequacy in the female groups as compared with that in the male groups. Vitamin E showed a better percentage of adequacy, and all females and almost all males had an adequate consumption of that vitamin (tab. III). Vitamin B6 was adequately consumed in 50% and 48% of the male groups 1 and 3, and in 60% and 62% of the female groups 2 and 4; therefore, no difference was observed among the groups. Vitamin B12 showed good levels of adequacy for both sexes. Folic acid was inadequately consumed by males in both groups, significantly different from the female consumption, independent of the severity of the disease (tab. III).
Discussion
The results obtained in the present study show no significant difference between the groups studied in regard to the severity of coronary artery disease for the anthropometric, biochemical, and dietary parameters assessed, because of the stratification of the sample with a reduced number of individuals in each group. Relevant associations, however, occurred when males and females were compared.
In regard to the anthropometric study, some deviations compatible with an increased risk for coronary artery disease were observed. These deviations were mainly represented by the following: body mass index > 25 kg/m2; percent body fat greater than 24 and 30 in males and females, respectively; and the waist/hip ratio greater than 0.98 and 0.90 in males and females, respectively. Gaudet et al 29 reported mean values of body mass index and waist/hip ratio in males with severe coronary artery disease of 28 kg/m2 and 0.96, respectively, compatible with the subsequent risk for acute ischemic events, such as acute myocardial infarction. Those authors concluded that body mass index, percent body fat, and waist/hip ratio were above the recommended values also in patients with cardiac disease confirmed on coronary arteriography.
Deprés and Lamarche 30 related the accumulation of abdominal fat with dyslipidemia, and these individuals were more susceptible to an increase in triglycerides and a reduction in HDL-cholesterol. Korhonen et al 31 observed significant differences in the lipid profile of patients with coronary artery disease with the degree of stenosis greater than 50%, lower than 50%, and individuals with no coronary artery disease, the profile of the first group having the greatest atherogenic potential. However, studies assessing the behavior of 2 or more risk indicators among individuals with coronary artery disease and coronary obstruction according to the severity of the lesion are still rare in the literature.
The biochemical analysis revealed a reduction in HDL-cholesterol in males, an increase in LDL-cholesterol in males and females, and total serum cholesterol above the recommended levels in all groups, according to the 2º Consenso Brasileiro de Dislipidemias 32. Similar results were observed in individuals undergoing coronary angiography for assessing coronary lesions in vivo 33 in a clinical assay carried out in postmenopausal females with coronary artery disease and previous acute myocardial infarction 34, and in a study 35 with dyslipidemic males and females with coronary artery disease. Individuals with these patterns of serum lipids have a greater predisposition to recurring events, such as angina pectoris, acute myocardial infarction or sudden death, or both 36,37.
In the present study, the total cholesterol/HDL-c ratio was compatible with the risk for coronary artery disease 38, mainly in males with severe lesions, and this was the only discriminating indicator of the severity of the lesion.
Hypertriglyceridemia and hyperglycemia were observed mainly in the females of both groups, independent of the extension of the coronary lesion. Hyperglycemia and diabetes mellitus are frequently observed in females. Pyorala et al 39 related positively fasting glycemia and atherosclerotic complications in nondiabetic individuals. Glycemic control of individuals with coronary artery disease improves the prognosis of coronary artery disease and reduces mortality 40,41. Hokanso and Austin 42 observed that high triglyceride levels correspond to a 75% higher risk in females with cardiac disease. Elisaf et al 43 found significant differences in the serum triglyceride levels of individuals with coronary artery lesions ³70% and those of individuals with coronary artery lesions <70%, strengthening the concept that triglyceride levels increase according to the severity of the coronary artery disease both in males and females, unlike our results 44.
Another biochemical parameter assessed that has been positively associated with the genesis of coronary artery disease is plasma homocysteine, considered by several authors an independent marker of early atherogenesis through still unclear mechanisms 45,46. Even though plasma homocysteine has been exhaustively studied, mainly in the past few years, its normal reference values are still a matter of controversy. The variations may be attributed to methodological differences in homocysteine measurement, in the processing of the sample, and in the selection of the individuals, because factors, such as age, sex, and menopause may influence homocysteinemia 47. In the present study, we used the values proposed by Ubbink et al 6, who adopted a mathematical predictor model to establish the normal range of fasting homocysteine, and we found that a significant percentage of males (30%) had homocysteine levels above the recommended values.
Ueland et al 47 adopted the cut point ³ 8.56 µmol/L for moderate homocysteinemia. When this cut point was adopted in our study, the percentage of hyperhomocysteinemic males increased to 45%. Bots et al 48 and Nygard et al 49 also reported increased plasma fasting homocysteine levels in males as compared with those of females, independent of the severity of the disease. The female homocysteine levels in our study were not comparable to those in the literature, because, according to Ridker et al 50, menopausal females are normally hyperhomocysteinemic.
Another important point to be considered is the low sensitivity of the measurements of fasting homocysteinemia. Dogamala et al 51 identified, after the overload test with methionine, hyperhomocysteinemia in 39% of the patients who had normal or borderline basal levels.
Cunha 52 reported that individuals with coronary artery disease and severe lesions had homocysteine levels above those found in the group with no coronary artery disease. Mayer et al 53 reported a directly proportional association between the degree of coronary artery obstruction and homocysteine levels.
Even though extremely high median values have not been found, the importance of this alteration should not be disregarded, mainly because it refers to patients with established coronary artery disease, who have other risk factors, such as dyslipidemia, increased body fat, and inadequate dietary allowance.
According to Malinow et al 54, the percentage of abnormally high homocysteine levels among individuals with coronary artery disease is approximately 20 to 30%, which is identical to the percentage observed in the males of the present study.
Dietary composition has other implications in coronary artery disease, it being important to monitor some risk factors, such as dyslipidemia, obesity, and hyperhomocysteinemia. In our study, an excessive intake of total lipids and cholesterol and an inadequate intake of unsaturated lipids were observed in both sexes. In regard to caloric dietary distribution and macronutrients, we observed the ingestion of diets with a high percentage of proteins and lipids and a low percentage of carbohydrates. Watts et al 55, analyzing the progression of coronary artery disease in the male sex, observed a significant association with the amount of total and unsaturated fat in the diet. The intake of a similar diet was observed by Knoop et al 56 in individuals with coronary artery disease with a lipid intake of 36% in the diet and a mean dietary cholesterol consumption of 320 mg/day. Singh et al 64 observed the ingestion of high-fat and high-protein diets in their group of patients with coronary artery disease; however, the amount of dietary fiber intake of their patients was greater than that observed in the present study, in which that amount was extremely inadequate for both sexes.
The antioxidant components are significant dietary factors that prevailed in the diets of the females, of which a greater percentage showed adequate amounts of vitamin C and a-tocopherol according to the NRC/RDA 21. These results were similar to those reported by Singh et al 58 in hospitalized patients with previous acute myocardial infarction.
Rosegren et al 59, studying patients who survived acute myocardial infarction, reported that the increased subsequent mortality risk was due to the maintenance of risk factors, such as smoking, dyslipidemia, and systemic arterial hypertension.
Our results showed that the individuals with coronary artery disease assessed in this study had alterations in risk factors, such as overweight, dyslipidemia, positive familial history for coronary artery disease, smoking, and inadequacy of dietary habits. These alterations were present in varied degrees according to sex and did no differ depending on the severity of the coronary artery lesion. Therefore, we observed the persistence of alterations in risk factors, even after the diagnosis of coronary artery disease, confirming the recurrence of ischemic events. This may have resulted from the lack of guidance and follow-up for correcting the risk factors that could be controlled.
18600-050 - Botucatu, SP, Brazil - E-mail: anyfer@fmb.unesp.br
English version by Stela Maris C. e Gandour
1. American Heart Association. Heart and stroke facts: 1995 statistical supplement. Dallas: AHA, 1994.Heart and stroke facts: 1995 statistical supplement19942. Hornstra G, Barth CA, Galli C, et al. Functional food science and the cardiovascular system. Br J Nutr 1998; 80(suppl 1): 113s-46s.Functional food science and the cardiovascular systemBr J Nutr1998113s46ssuppl 180HornstraGBarthCAGalliC3. Danchin N, Vaur L, Genés N, et al. Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. J Am Coll Cardiol 1997; 30: 1598-605.Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital resultsJ Am Coll Cardiol1997159860530DanchinNVaurLGenésN4. Wood D, Backer G, Faergeman O, Graham I, Mancia G, Pyörala K. Prevention of coronary disease in clinical practice: Recommendations of the second task force of European and other Societies on coronary prevention. Atherosclerosis 1998; 140: 199-270.Prevention of coronary disease in clinical practice: Recommendations of the second task force of European and other Societies on coronary preventionAtherosclerosis1998199270140WoodDBackerGFaergemanOGrahamIManciaGPyöralaK5. Summary of the report of the national cholesterol education program (NCEP)- Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment panel II). JAMA 1996; 269: 3015-23.Summary of the report of the national cholesterol education program (NCEP)- Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment panel II)JAMA19963015232696. Ubbink JB, Becker PJ, Vermaak H, Delport R. Results of B-vitamin supplementation study in a prediction model to define a reference range for plasma homocysteine. Clin Chem 1994; 41: 1033-7.Results of B-vitamin supplementation study in a prediction model to define a reference range for plasma homocysteineClin Chem19941033741UbbinkJBBeckerPJVermaakHDelportR7. World Health Organization. Diet, nutrition and preventing of chronic diseases. Geneva: WHO, 1990 (Reports of WHO).Diet, nutrition and preventing of chronic diseases19908. Sociedade de Cardiologia do Estado de São Paulo. Cardiologia/SOCESP. São Paulo: Atheneu, 1996.Cardiologia/SOCESP19969. Lohman TG, Roche AF, Martorell R. Anthropometrics standardization reference manual. Illinois: Human Kinetics Books, 1998.Anthropometrics standardization reference manual1998LohmanTGRocheAFMartorellR10. Pollock ML, Willmore JH. Exercício na saúde e na doença: avaliação e prescrição para prevenção e reabilitação. 2ª Ed. Rio de Janeiro: Medsi, 1993.Exercício na saúde e na doença: avaliação e prescrição para prevenção e reabilitação1993PollockMLWillmoreJH11. Frisancho AR. Anthropometrics standards for the assessment of growth and nutritional status. The University of Michigan Press, 1990.Anthropometrics standards for the assessment of growth and nutritional status1990FrisanchoAR12. Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skin fold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 77: 5-7.Body fat assessed from total body density and its estimation from skin fold thickness: measurements on 481 men and women aged from 16 to 72 yearsBr J Nutr19745777DurninJVGAWomersleyJ13. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: WHO 1998 (Reports of WHO. Consultation on obesity).Obesity: preventing and managing the global epidemic199814. Frisancho AR. Anthropometrics standards for the assessment of growth and nutritional status. The university of Michigan press, 1990.Anthropometrics standards for the assessment of growth and nutritional status1990FrisanchoAR15. Bray GA. Classificação e avaliação das obesidades. In: Obesidade: Conceitos Básicos e Aplicações Clínicas. Clin Med Am Norte 1989; 1: 189-216.Classificação e avaliação das obesidadesClin Med Am Norte19891892161BrayGA16. Katch FI, Katch VL. The body composition profile: techniques of measurement and applications. Clin Sports Med 1984; 3: 31.The body composition profile: techniques of measurement and applicationsClin Sports Med1984313KatchFIKatchVL17. Inan - Brasil, Ministério da Saúde. Registro fotográfico para inquéritos dietéticos: utensílios e porções. Brasília, 1996.Registro fotográfico para inquéritos dietéticos: utensílios e porções199618. Soares EA, Portela ESS, Ishi M. Relação de medidas caseiras de 320 alimentos e respectivas gramagens. São Paulo: Ceane, 1991.Relação de medidas caseiras de 320 alimentos e respectivas gramagens1991SoaresEAPortelaESSIshiM19. Pinheiro ABV, Lacerda EAM, Benzecry EH, Gomes MCS, Costa VM. Tabela para avaliação de consumo alimentar em medidas caseiras. Rio de Janeiro (s.ed), 1996.Tabela para avaliação de consumo alimentar em medidas caseiras1996PinheiroABVLacerdaEAMBenzecryEHGomesMCSCostaVM20. Philippi ST, Szarfarc SC, Latterza AR. Virtual Nutry - versão 1.0 for windows. São Paulo: Faculdade de Saúde Pública - USP, 1996.Virtual Nutry - versão 1. 0 for windows1996PhilippiSTSzarfarcSCLatterzaAR21. National Research Council. Recommended dietary allowances. 10th ed., Washington: National Academy of Science, 1989.Recommended dietary allowances198922. Ubbink JB, Vermaak WJH, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromat 1991; 565: 441-6.Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serumJ Chromat19914416565UbbinkJBVermaakWJHBissbortS23. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClin Chem197249950218FriedwaldWTLevyRIFredricksonDS24. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986; 256: 2835-8.Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham StudyJAMA198628358256CastelliWPGarrisonRJWilsonPWAbbottRDKalousdianSKannelWB25. Consenso Brasileiro sobre Dislipidemias. Avaliação Detecção - Tratamento. Arq Bras Cardiol 1996; 67: 109-22.Avaliação - Detecção - TratamentoArq Bras Cardiol1996109226726. American Diabetes Association. Complete guide to diabetes. Alexandria: American Diabetes Association, 1997.Complete guide to diabetes199727. Siegel S. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill, 1965.Nonparametric statistics for the behavioral sciences1965SiegelS28. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: WHO, 1998 (Reports of WHO. Consultation on obesity).Obesity: preventing and managing the global epidemic199829. Gaudet D, Vohl MC, Perron P, et al. Relationship of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. Circulation 1998; 97: 871-7.Relationship of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor geneCirculation1998871797GaudetDVohlMCPerronP30. Deprés JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 1993; 6: 137-59.Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular diseaseNutr Res Rev1993137596DeprésJPLamarcheB31. Korhonen T, Savolainen MJ, Koistinem JM, et al. Association of lipoprotein cholesterol and tryglicerides with the severity of coronary artery disease in men and women. Atherosclerosis 1996; 127: 213-20.Association of lipoprotein cholesterol and tryglicerides with the severity of coronary artery disease in men and womenAtherosclerosis199621320127KorhonenTSavolainenMJKoistinemJM32. Consenso Brasileiro sobre Dislipidemias. Avaliação Detecção - Tratamento. Arq Bras Cardiol 1996; 67: 109-22.Avaliação - Detecção - TratamentoArq Bras Cardiol1996109226733. Kitamura K, Mizuno K, Miyamoto A, Nakamura H. Serum lipid and the presence of yellow plaque in coronary lesions in vivo. Am J Cardiol 1997; 79: 676-8.Serum lipid and the presence of yellow plaque in coronary lesions in vivoAm J Cardiol1997676879KitamuraKMizunoKMiyamotoANakamuraH34. Lewis SJ, Sacks FM, Mitchell JS, et al. Pravastatin effects on cardiovascular events in women after myocardial infarction: The Cholesterol Study. J Am Coll Cardiol 1999; 32: 140-6.Pravastatin effects on cardiovascular events in women after myocardial infarction: The Cholesterol StudyJ Am Coll Cardiol1999140632LewisSJSacksFMMitchellJS35. Andrews TC, Raby K, Barry J, et al. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation 1997; 95: 324-8.Effect of cholesterol reduction on myocardial ischemia in patients with coronary diseaseCirculation1997324895AndrewsTCRabyKBarryJ36. Rose G, Hamilton PJ, Keen H, Reid DD, MC Cartney P, Jarret RJ. Myocardial ischemia, risk factors and death from coronary heart disease. Lancet 1997; Volume??: 105-9.Myocardial ischemia, risk factors and death from coronary heart diseaseLancet19971059RoseGHamiltonPJKeenHReidDDMCCartney PJarretRJ37. Andrews TC, Raby K, Barry J, et al. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation 1997; 95: 324-8.Effect of cholesterol reduction on myocardial ischemia in patients with coronary diseaseCirculation1997324895AndrewsTCRabyKBarryJ38. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986; 256: 2835-8.Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham StudyJAMA198628358256CastelliWPGarrisonRJWilsonPWAbbottRDKalousdianSKannelWB39. Pyorala K. Preventive Cardiology: a progress report. Prev Med 1990; 19: 78-96.Preventive Cardiology: a progress reportPrev Med1990789619PyoralaK40. Uusitupa MIJ, Niskanen LK, Siitonem O, Voutilainem E, Pyörala K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993; 36: 1175.Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjectsDiabetologia1993117536UusitupaMIJNiskanenLKSiitonemOVoutilainemEPyöralaK41. Anderson DKG. Diabetes mellitus in a defined population. A longitudinal study with special reference to early diagnosis, occurrence and mortality. Comprehensive summaries of Upscale dissertations from the Faculty of Medicine. Stockholm: Almqvist and Wiksell International, 1994.Diabetes mellitus in a defined population. A longitudinal study with special reference to early diagnosis, occurrence and mortality: Comprehensive summaries of Upscale dissertations from the Faculty of Medicine1994AndersonDKG42. Hokanso JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 3: 213-9.Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studiesJ Cardiovasc Risk199621393HokansoJEAustinMA43. Elisaf MS, Siamopoulos KC, Tselegarides TL, et al. Lipid abnormalities in Greek patients with coronary artery disease. Intern J Cardiol 1997; 59: 177-84.Lipid abnormalities in Greek patients with coronary artery diseaseIntern J Cardiol19971778459ElisafMSSiamopoulosKCTselegaridesTL44. Korhonen T, Savolainen MJ, Koistinem JM, et al. Association of lipoprotein cholesterol and tryglicerides with the severity of coronary artery disease in men and women. Atherosclerosis 1996; 127: 213-20.Association of lipoprotein cholesterol and tryglicerides with the severity of coronary artery disease in men and womenAtherosclerosis199621320127KorhonenTSavolainenMJKoistinemJM45. Stampfer MJ, Malinow MR, Willet MWC. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-81.A prospective study of plasma homocysteine and risk of myocardial infarction in US physiciansJAMA199287781268StampferMJMalinowMRWilletMWC46. Kang SS, Wong PKW, Malinow MR. Hyperhomocist(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992; 2: 279-98.Hyperhomocist(e)inemia as a risk factor for occlusive vascular diseaseAnnu Rev Nutr1992279982KangSSWongPKWMalinowMR47. Ueland PM, Refsum H, Stabler SP, Malinow RM, Anderson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764-79.Total homocysteine in plasma or serum: methods and clinical applicationsClin Chem199317647939UelandPMRefsumHStablerSPMalinowRMAndersonAAllenRH48. Bots ML, Launer LJ, Lindemans J, et al. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly. Arch Intern Med 1999; 159: 38-44.Homocysteine and short-term risk of myocardial infarction and stroke in the elderlyArch Intern Med19993844159BotsMLLaunerLJLindemansJ49. Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998, 67: 263-70.Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine StudyAm J Clin Nutr19982637067NygardORefsumHUelandPMVollsetSE50. Ridker PM, Manson JE, Buring JE, Matias M, Hennekens CH. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA 1999; 281: 1817-21.Homocysteine and risk of cardiovascular disease among postmenopausal womenJAMA1999181721281RidkerPMMansonJEBuringJEMatiasMHennekensCH51. Dogamala TB, Libura M, Szczeklik A. Hyperhomocisteinemia following oral methionine load is associated with increased lipid peroxidation. Thromb Res 1997; 8794: 411-6.Hyperhomocisteinemia following oral methionine load is associated with increased lipid peroxidationThromb Res199741168794DogamalaTBLiburaMSzczeklikA52. Cunha CLP. Homocisteína e doença arterial coronariana - estudo em 195 pacientes submetidos a cineangiocoronariografia (Dissertação). Curitiba: Universidade Federal do Paraná, 1997.Homocisteína e doença arterial coronariana: estudo em 195 pacientes submetidos a cineangiocoronariografia1997CunhaCLP53. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1995; 27: 517-27.Homocysteine and coronary atherosclerosisJ Am Coll Cardiol19955172727MayerELJacobsenDWRobinsonK54. Malinow MR, Kang SS, Taylor LM, et al. Prevalence of hyperhomocist(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989; 79: 1180-8.Prevalence of hyperhomocist(e)inemia in patients with peripheral arterial occlusive diseaseCirculation19891180879MalinowMRKangSSTaylorLM55. Watts GF, et al. Nutrient intake and progression of coronary artery disease. Am J Cardiol 1994; 73: 328-32.Nutrient intake and progression of coronary artery diseaseAm J Cardiol19943283273WattsGF56. Knoop RH, Walden CE, Retzlaff BM, et al. Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study. JAMA 1997; 278: 1509-15.Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men: The Dietary Alternatives StudyJAMA1997150915278KnoopRHWaldenCERetzlaffBM57. Singh RB, Rastogi SS, Verma R, et al. Randomized controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. Br Med J 1992; 304: 1015-9.Randomized controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow upBr Med J199210159304SinghRBRastogiSSVermaR58. Singh RB, Niaz MA, Agarwal P, Begom R, Rastogi SS. Effect of antioxidant-rich foods on plasma ascorbic acid, cardiac enzyme, and lipid peroxide levels in patients hospitalized with acute myocardial infarction. J Am Diet Assoc 1995; 95: 775-80.Effect of antioxidant-rich foods on plasma ascorbic acid, cardiac enzyme, and lipid peroxide levels in patients hospitalized with acute myocardial infarctionJ Am Diet Assoc19957758095SinghRBNiazMAAgarwalPBegomRRastogiSS59. Rosegren A, Wilhelmsen L, Hagman M, Wedel H. Natural history of myocardial infarction and angina pectoris in a general population sample of middle-aged men: a 16-year follow-up of the Primary Prevention Study, Göterborg, Sweden. J Intern Med 1998; 244: 495-505.Natural history of myocardial infarction and angina pectoris in a general population sample of middle-aged men: a 16-year follow-up of the Primary Prevention Study, Göterborg, SwedenJ Intern Med1998495505244RosegrenAWilhelmsenLHagmanMWedelH